Document:

Exhibit
10.26

 

	TO:	Clever Leaves International Inc. (formerly, Northern Swan Holdings, Inc.) (the “Company”)
	 	 
	RE:	The Notes (as such term is defined in the amended and restated intercreditor and collateral agency agreement dated May 10, 2019 (the “Intercreditor Agreement”))  among, the Company, as issuer, GLAS Americas LLC, as collateral agent, GLAS USA LLC, as paying agent, and the noteholders party thereto from time to time.
	 	 
	DATE:	March 26, 2020

  

AMENDMENT,
CONSENT AND WAIVER AGREEMENT

 

WHEREAS
all capitalized terms used in this amendment, consent and waiver agreement (this “Agreement”) and not otherwise
defined herein shall have the meanings ascribed thereto in the Intercreditor Agreement.

 

AND
WHEREAS (i) Neem Holding, LLC (the “Subscriber”)  is
the holder of Class C Preferred Shares, (ii) the Subscriber or one of its affiliates or an affiliate of Farallon Capital Management
LLC has agreed to subscribe for and purchase 936,364 class D preferred shares issued in the capital of the Company (the “Class
D Preferred Shares”)  for an aggregate purchase
price of USD$10,300,004, upon the terms and subject to the conditions set out in the subscription agreement dated on or about the
date hereof (the “Subscription Agreement”)  among
the Company and the Subscriber; and (iii) in accordance with the Subscription Agreement, the Subscriber has the right, but not
the obligation, to cause the Company to purchase up to 711,035 Class C Preferred Shares from the Subscriber for a maximum aggregate
purchase price of USD$6,249,997.65 (the “Put Right”). 

 

AND
WHEREAS in connection with, among other things, the Subscription Agreement, the Company wishes to (i) amend each of the Notes
to provide for an increase in the rate of interest payable on the Principal Amount owing under the Notes and to provide that such
interest be payable in-kind, (ii) amend the restrictive covenants provided for under the Notes to allow for the creating, incurrence
or assumption of certain additional debt; (iii) consent to the exercise of the Put Right by the Subscriber; and (iv) extend the
date on which the Company is required to deliver its audited year-end financial statements.

 

NOW
THEREFORE for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the undersigned,
the undersigned agree as follows:

 

	1.	AMENDMENTS

 

	1.1	Definitions. Each
    Note is hereby amended by inserting the following definition in alphabetical sequence in Section 1.1 of each Note:

 

“Refinancing
Indebtedness” shall mean refinancings, replacements, renewals or extensions of debt so long as such refinancings, replacements,
renewals, or extensions do not result in an increase in the principal amount of the debt so refinanced, replaced, renewed, or
extended (beyond any such limit provided for in Section 6.5 (and provided that the proceeds of any such increase in the principal
amount of such debt are received in cash)), other than by the amount of premiums paid thereon and the fees and expenses incurred
in connection therewith and by the amount of unfunded commitments with respect thereto.

 

    	 		 

     

    

 

	1.2	Term, Interest
    and Payment. Each Note is hereby amended by deleting Section 2.2.1 of each Note in its entirety and replacing it with
    the following:

 

“2.2.1
Interest shall accrue on the whole amount of the Principal Amount outstanding and remaining from time to time unpaid, commencing
from the date hereof and continuing both before and after the Maturity Date, default and judgment until actual payment in full
of this Convertible Note or conversion as hereinafter provided, at the annual interest rate of ten percent (10%) calculated and
compounded quarterly in arrears on March 31, June 30, September 30 and December 31 of each year (commencing on March 31, 2019)
and payable on the earliest of (i) the Maturity Date; (ii) repayment of the Principal Amount or any part thereof (for certainty,
interest shall only be paid on such amount of the Principal Amount as is being repaid); and (iii) following the occurrence of
an Event of Default which is continuing, receipt of written notice by the Company from the Agent that the Obligations are due
and payable. Interest shall be computed on the basis of the actual number of days elapsed divided by 365 or 366, as the case may
be, compounded quarterly. Principal and interest shall be payable in lawful money of the United States of America, and shall be
paid to the Paying Agent at 3 Second Street, Suite 206, Jersey City, NJ 07311 or at such other place as the Paying Agent may have
designated from time to time in writing to the Company.”.

 

	1.3	Each Note is hereby amended by replacing the
    text “10%” in Section 2.2.2 of each Note with the following:

 

“12%”.

 

	1.4	Each Note is hereby amended by deleting Section
    6.2.1 of each Note in its entirety and replacing it with the following:

 

“[Intentionally
deleted.]”.

 

	1.5	The following is added as Section 6.5 to each
    Note:

 

“6.5
Negative Covenant regarding Debt. The Company hereby covenants and agrees with the Lender that the Company will not, and
shall ensure that each of its subsidiaries shall not, without the prior written consent of the Lender, create, incur or assume
any debt, except for (i) Subordinated Debt, (ii) debt created, incurred or assumed by Herbal Brands, Inc., provided that (A) the
proceeds of such debt are received in cash, (B) such debt does not, in the aggregate, exceed Eight Million Five Hundred Thousand
United States Dollars (US$8,500,000) and (C) such debt is non-recourse to the Obligors (other than Herbal Brands, Inc.), and any
Refinancing Indebtedness in respect of such debt, and (iii) debt created, incurred or assumed by any one or more direct or indirect
subsidiaries of the Company including, but not limited to, Ecomedics S.A.S. (operating as Clever Leaves), provided that (A) the
proceeds of such debt are received in cash and provided further that such debt does not (excluding the debt set forth in clause
(ii) above), exceed Ten Million United States Dollars (US$10,000,000) in the aggregate, at any time, (B) such debt is for general
corporate purposes, acquisitions, asset purchases, capital expenditures and any refinancing of Subordinated Debt only, and (C)
such debt does not replace, repay or refinance any debt set forth in clause (ii) above and is not used in exchange for any such
debt or any equity of the Company or any of its direct or indirect subsidiaries, and any Refinancing Indebtedness in respect of
such debt.”

 

    	 	2	 

     

    

 

	1.6	Each Note is hereby amended by replacing Subsection
    6.2.2(ii) of each Note in its entirety and replacing it with the following:

 

“(ii)
guarantees in respect of debt permitted by Section 6.5 below provided by any direct or indirect subsidiary of the Company, other
than Northern Swan International, Inc., and provided that such guarantee is subject to a subordination agreement in form and substance
reasonably satisfactory to the Lender, or”.

 

	1.7	Each Note is hereby
    amended by replacing Subsection 6.2.3(ii) of each Note in its entirety and replacing it with the following:

 

“(ii)
debt permitted by Section 6.2.2 above or Section 6.5 below;”.

 

	1.8	Each Note is hereby amended by deleting Section
    7.1.6 of each Note in its entirety and replacing it with the following:

 

“7.1.6
Authorized Capital. The authorized capital of the Company consists of: (A) the following common shares: (i) an unlimited
number of class A voting common shares, of which 19,266,610 are issued and outstanding as of the date hereof; (ii) an unlimited
number of class B voting common shares, of which 0 are issued and outstanding as of the date hereof; (iii) an unlimited number
of class C non-voting common shares, of which 0 are issued and outstanding as of the date hereof; (iv) an unlimited number of
class D preferred shares; and (B) an unlimited number of Class C Preferred Shares, of which 5,988,957 Class C Preferred Shares
are issued and outstanding as of the Business Day immediately preceding the date hereof. Except pursuant to the Loan Documents,
(i) other than (A) in connection with the proposed private placement of up to 4,090,916 class D preferred shares at a price of
$11.00 per class D preferred share, (B) 3,634,504 stock options exercisable for class A voting shares of the Company, (C) warrants
to purchase 28,922 class A voting common shares, (D) warrants to purchase 193,402 Class C Preferred Shares, (E) options and shares
reserved under the Company’s 2018 Omnibus Incentive Compensation Plan for issuance to employees in accordance with the terms
thereof, and (F) rights of certain management of the Company to obtain 5,625,572 class A voting common shares in connection with
the Company’s October 31, 2019 acquisition of the outstanding minority interest in the Company’s subsidiary Eagle
Canada Holdings, Inc., the Company does not have any outstanding agreement, subscription, warrant, option or commitment (nor has
it granted any right or privilege capable of becoming an agreement, subscription, warrant, option or commitment) obligating it
to issue or sell any Common Shares or other securities, including any security or obligation of any kind convertible into or exchangeable
for Common Shares or other security and (ii) there is no outstanding share or stock appreciation right, phantom equity, restricted
share unit, deferred share unit or similar right, agreement, arrangement or commitment based on the market price of the Common
Shares or the income or any other attribute of the Company or any of its subsidiaries. Except for the amended and restated shareholders
agreement dated March 30, 2019 among the Company and each of the shareholders listed on Schedule A thereto, the Investor Rights
Agreement dated March 30, 2019 among the Company and certain investors listed on Schedule A thereto and the Voting Support and
Consultation Agreement, dated October 31, 2019, by and among the Company, Andrés Fajardo, Gustavo Escobar, Julián
Wilches, Daniel Montana, Kyle Detwiler, Delroy Wright and Joseph Salameh, there is no outstanding shareholder agreement, proxy,
voting trust, right to require registration under any applicable securities legislation or any other arrangement or commitment
to which the Company or any of its subsidiaries is a party or bound, with respect to the voting, disposition or registration of
any outstanding securities of the Company or any of its subsidiaries.”.

 

    	 	3	 

     

    

 

	2.	CONSENT TO PUT RIGHT

 

	2.1	The Noteholders
    hereby consent to the exercise by the Subscriber of the Put Right, the execution and delivery of all documents, instruments
    and agreements by the Company in connection therewith, the performance by the Company of all of its obligations thereunder
    and the entering into and consummation of any and all transactions contemplated thereby and waive any Event of Default that,
    absent the consent provided for herein, would arise therefrom.

 

	3.	WAIVER

 

	3.1	The Noteholders
    agree that notwithstanding Section 6.3.4 of the Notes, the Company shall deliver its audited year-end financial statements
    in respect of the fiscal year-ended December 31, 2019, accompanied by management’s discussion and analysis and a copy of the
    Company’s auditor’s letter to management, to the Noteholders on the later of: (i) June 30, 2020; (ii) 60 days following the
    end of any extended timeframe upon which reporting issuers have been granted an extension in order to provide financial reporting
    to the Securities Exchange Commission resulting from the effects of COVID-19.

 

	4.	REPRESENTATIONS
    AND WARRANTIES

 

	4.1	The Company and
    each of the Guarantors (as defined in each of the Notes) represents, warrants and covenants as follows:

 

	4.1.1	each of the statements
    contained in this Agreement are true and accurate in all respects and fully and completely disclose all material information
    with respect to their subject matter;

 

	4.1.2	all corporate action
    necessary for the authorization, execution, delivery and performance of this Agreement by each of the Company and Guarantors
    have been duly authorized and taken;

 

	4.1.3	this Agreement,
    when duly executed and delivered by each of the Company and Guarantors will constitute a legal, valid and binding obligation,
    enforceable against each of them in accordance with its terms; and

 

	4.1.4	all representations
    and warranties set out in each of the Notes as they relate to the Company and Guarantors shall be deemed to have been repeated
    on the date of this Agreement (except to the extent that such representation or warranty expressly relates solely to an earlier
    date or period in which case it is true and correct as of such earlier date or period) and shall continue in effect for so
    long as the Company is indebted to the Noteholders pursuant to the Notes or any of them, subject to any amendments contained
    herein.

 

	5.	MISCELLANEOUS

 

	5.1	This Agreement is
    supplemental to the Notes. The Notes and Loan Documents (as defined in each Note) remain in full force and effect, as amended
    hereby, and are hereby ratified and confirmed in all respects. Each of the Company and Guarantors will comply with all reporting
    requirements, financial covenants and non-financial covenants and all other terms set forth in each of the Notes and other
    Loan Documents, as amended hereby, and all other documentation executed and delivered to the Noteholders in connection therewith.

 

    	 	4	 

     

    

 

	5.2	Each of the Company and Guarantors hereby agrees to
duly execute and deliver or cause to be executed or delivered such further instruments, agreements or similar documents as may
be necessary to carry out the provisions and purposes of this Agreement. 

 

	5.3	The execution, delivery and effectiveness of this Agreement shall not constitute a waiver of any provision contained in the Notes or Loan Documents, except as specifically set forth herein.
	 	 
	5.4	Each Secured Party reserves all rights and remedies under each of the Notes and other Loan Documents.
	 	 
	5.5	This Agreement shall be governed by and interpreted in accordance with the laws of British Columbia and the federal laws of Canada applicable therein.
	 	 
	5.6	 This Agreement may be executed and delivered in original, facsimile or portable
    document format (pdf) form.

 

DATED
as of the date first written above. 

 

	 	CLEVER LEAVES INTERNATIONAL INC.
	 	 	 	 
	 	By:	/s/
    Kyle Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	CEO
	 	 	 	 
	 	NS US HOLDINGS, INC.
	 	 	 	 
	 	By:	/s/ Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	CEO
	 	 	 	 
	 	HERBAL BRANDS, INC.
	 	 	 	 
	 	By:	/s/ Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	 
	 	 	 	 
	 	NORTHERN SWAN INTERNATIONAL, INC.
	 	 	 	 
	 	By:	/s / Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	 

 

    	 	5	 

     

    

 

 

	 	NORTHERN SWAN MANAGEMENT, INC.
	 	 	 	 
	 	By:	/s/ Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	 
	 	 	 	 
	 	NORTHERN SWAN DEUTSCHLAND  HOLDINGS, INC.
	 	 	 	 
	 	By:	/s/ Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	 
	 	 	 	 
	 	NORTHERN SWAN PORTUGAL HOLDINGS, INC.
	 	 	 	 
	 	By:	/s/ Kyle
    Detwiler
	 	 	Name:	Kyle Detwiler
	 	 	Title:	 

 

    	 	6	 

     

    

 

	 	GLAS AMERICAS LLC

	 	 	 	 
	 	By:	/s/ Adam Berman
	 	 	Name:	Adam Berman

	 	 	Title:	Vice President 

 

	 	GLAS USA LLC

	 	 	 	 
	 	By:	/s/ Adam Berman
	 	 	Name:	Adam Berman

	 	 	Title:	Vice President 

 

	 	RIMROCK HIGH INCOME PLUS (MASTER FUND),
                    LTD

	 	 	 	 
	 	By:	/s/ Steve Foulke
	 	 	Name:	Steve Foulke

	 	 	Title:	MD

 

	 	ANSON INVESTMENTS MASTER FUND LP by
                    its co-investment advisor, ANSON ADVISORS INC.

	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam

	 	 	Title:	Director of Anson Advisors Inc, co-investment advisor of the
Holder

 

	 	ANSON OPPORTUNITIES MASTER FUND LP
                    by its co-investment advisor, ANSON ADVISORS INC.

	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam

	 	 	Title:	Director of Anson Advisors Inc, co-investment advisor of the
Holder

 

	 	ANSON EAST MASTER FUND LP by its co-investment
                    advisor, ANSON ADVISORS INC.

	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam

	 	 	Title:	Director of Anson Advisors Inc, co-investment advisor of the
Holder

 

	 	AC ANSON INVESTMENTS LTD.

	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam

	 	 	Title:	

  

	 	AXIOS GROWTH PARTNERS, LLC

	 	 	 	 
	 	By:	/s/ Nicholas Rutherfurd
	 	 	Name:	Nicholas Rutherfurd

	 	 	Title:	Partner

 

	 	NS CO-INVESTMENT LLC

	 	 	 	 
	 	By:	/s/ Owen Littman
	 	 	Name:	Owen Littman

	 	 	Title:	Authorized Signatory

 

	 	COWEN AND COMPANY LLC, as Noteholder,
                    by COWEN HOLDINGS, INC. its sole member

	 	 	 	 
	 	By:	/s/ Owen Littman
	 	 	Name:	Owen Littman

	 	 	Title:	Authorized Signatory

   

 

7Exhibit
10.27

 

		TO:	Clever
                                         Leaves International Inc. (formerly, Northern Swan Holdings, Inc.) (the “Company”)

 

		RE:	The
                                         Notes (as such term is defined in the amended and restated intercreditor and collateral
                                         agency agreement dated May 10, 2019 (the “Intercreditor Agreement”))
                                         among, the Company, as issuer, GLAS Americas LLC, as collateral agent, GLAS USA LLC,
                                         as paying agent, and the noteholders party thereto from time to time.

 

		DATE:	June
                                         23, 2020

 

AMENDMENT,
CONSENT AND WAIVER AGREEMENT NO.2

 

WHEREAS
all capitalized terms used in this amendment, consent and waiver agreement (this “Agreement”) and not otherwise
defined herein shall have the meanings ascribed thereto in the Intercreditor Agreement.

 

AND
WHEREAS the undersigned entered into an amendment, consent and waiver agreement dated March 26, 2020, which provided for, among
other things, amendments to the Notes so as to increase the rate of interest payable on the Principal Amount owing under the Notes
and to provide that such interest be payable in kind.

 

AND
WHEREAS the undersigned wish to clarify that the amendments to Section 2.2.1 of the Notes described in the recital above were
to have been made effective as of January 1, 2020.

 

NOW
THEREFORE for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the undersigned,
the undersigned agree as follows:

 

		1.	AMENDMENTS

 

		1.1	Term,
                                         Interest and Payment. Each Note is hereby amended by deleting Section 2.2.1 of each
                                         Note in its entirety and replacing it with the following:

 

“2.2.1 Interest
shall accrue on the whole amount of the Principal Amount outstanding and remaining from time to time unpaid:

 

		(i)	from
                                         the date hereof until December 31, 2019, at the annual interest rate of eight percent
                                         (8%) compounded and payable, in cash, quarterly in arrears on March 31, 2019, June 30,
                                         2019, September 30, 2019 and December 31, 2019; and

 

		(ii)	from
                                         January 1, 2020 and continuing both before and after the Maturity Date, default and judgment
                                         until actual payment in full of this Convertible Note or conversion as hereinafter provided,
                                         at the annual interest rate of ten percent (10%) calculated and compounded quarterly
                                         in arrears on March 31, June 30, September 30 and December 31 of each year (commencing
                                         March 31, 2020) and payable on the earliest of (i) the Maturity Date; (ii) repayment
                                         of the Principal Amount or any part thereof (for certainty, interest shall only be paid
                                         on such amount of the Principal Amount as is being repaid); and (iii) following the occurrence
                                         of an Event of Default which is continuing, receipt of written notice by the Company
                                         from the Agent that the Obligations are due and payable.

 

     

     

    

 

Interest
shall be computed on the basis of the actual number of days elapsed divided by 365 or 366, as the case may be, compounded quarterly.
Principal and interest shall be payable in lawful money of the United States of America, and shall be paid to the Paying Agent
at 3 Second Street, Suite 206, Jersey City, NJ 07311 or at such other place as the Paying Agent may have designated from time
to time in writing to the Company.”.

 

		2.	REPRESENTATIONS
                                         AND WARRANTIES

 

		2.1	The
                                         Company and each of the Guarantors (as defined in each of the Notes) represents, warrants
                                         and covenants as follows:

 

		2.1.1	each
                                         of the statements contained in this Agreement are true and accurate in all respects and
                                         fully and completely disclose all material information with respect to their subject
                                         matter;

 

		2.1.2	all
                                         corporate action necessary for the authorization, execution, delivery and performance
                                         of this Agreement by each of the Company and Guarantors have been duly authorized and
                                         taken;

 

		2.1.3	this
                                         Agreement, when duly executed and delivered by each of the Company and Guarantors will
                                         constitute a legal, valid and binding obligation, enforceable against each of them in
                                         accordance with its terms; and

 

		2.1.4	all
                                         representations and warranties set out in each of the Notes as they relate to the Company
                                         and Guarantors shall be deemed to have been repeated on the date of this Agreement (except
                                         to the extent that such representation or warranty expressly relates solely to an earlier
                                         date or period in which case it is true and correct as of such earlier date or period)
                                         and shall continue in effect for so long as the Company is indebted to the Noteholders
                                         pursuant to the Notes or any of them, subject to any amendments contained herein.

 

		3.	MISCELLANEOUS

 

		3.1	This
                                         Agreement is supplemental to the Notes. The Notes and Loan Documents (as defined in each
                                         Note) remain in full force and effect, as amended hereby, and are hereby ratified and
                                         confirmed in all respects. Each of the Company and Guarantors will comply with all reporting
                                         requirements, financial covenants and non-financial covenants and all other terms set
                                         forth in each of the Notes and other Loan Documents, as amended hereby, and all other
                                         documentation executed and delivered to the Noteholders in connection therewith.

 

		3.2	Each
                                         of the Company and Guarantors hereby agrees to duly execute and deliver or cause to be
                                         executed or delivered such further instruments, agreements or similar documents as may
                                         be necessary to carry out the provisions and purposes of this Agreement.

 

		3.3	The
                                         execution, delivery and effectiveness of this Agreement shall not constitute a waiver
                                         of any provision contained in the Notes or Loan Documents, except as specifically set
                                         forth herein.

 

		3.4	Each
                                         Secured Party reserves all rights and remedies under each of the Notes and other Loan
                                         Documents.

 

		3.5	This
                                         Agreement shall be governed by and interpreted in accordance with the laws of British
                                         Columbia and the federal laws of Canada applicable therein.

 

		3.6	This
                                         Agreement may be executed and delivered in original, facsimile or portable document format
                                         (pdf) form.

 

(the
remainder of the page has been left intentionally blank; execution pages follow)

 

    2

     

    

 

DATED
as of the date first written above. 

 

	 	CLEVER LEAVES INTERNATIONAL INC.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler 
	 	 	Title:	CEO

  

	 	NS US Holdings, Inc.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler 
	 	 	Title:	CEO

  

	 	Herbal Brands, Inc.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler 
	 	 	Title:	President

  

	 	Northern Swan International, Inc.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler 
	 	 	Title:	Director

 

	 	Northern Swan Management, Inc.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler  
	 	 	Title:	Director

 

	 	Northern Swan Deutschland Holdings, Inc.
	 	 	 	 
	 	By:	/s/ Kyle Detwiler
	 	 	Name:	Kyle Detwiler 
	 	 	Title:	Director

 

    3

     

    

 

	 	Northern Swan Portugal Holdings, Inc.
	 	 	 	 
	 	By:	

                    /s/ Kyle
Detwiler

	 	 	Name:	Kyle Detwiler 
	 	 	Title:	 CEO

 

	 	GLAS AMERICAS LLC
	 	 	 	 
	 	By:	/s/ Diana Gulyan, AVP
	 	 	Name:	Diana Gulyan, AVP
	 	 	Title:	 

 

	 	GLAS USA LLC
	 	 	 	 
	 	By:	/s/ Diana Gulyan, AVP
	 	 	Name:	Diana Gulyan, AVP
	 	 	Title:	 

 

	 	Rimrock High Income Plus (Master) Fund, Ltd.
	 	 	 	 
	 	By:	/s/ Steve Foulke, MD
	 	 	Name:	Steve Foulke, MD
	 	 	Title:	 

 

	 	Anson INVESTMENTS MASTER FUND LP by its co-investment advisor, ANSON ADVISORS INC.
	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam
	 	 	
        Title: 
	Director
	 	 	 	 
	 	Anson OPPORTUNITIES MASTER FUND LP by its co-investment advisor, ANSON ADVISORS INC. 
	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam
	 	 	Title:	
        Director

	 	 	 	 
	 	Anson EAST MASTER FUND LP by its co-investment advisor, ANSON ADVISORS INC. 
	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam

 

    4

     

    

 

	 	AC Anson INVESTMENTS LTD. 
	 	 	 	 
	 	By:	/s/ Moez Kassam
	 	 	Name:	Moez Kassam
	 	 	Title:	Director of Anson Advisors Inc., its investment advisor

 

	 	axios growth partners, llc
	 	 	 	 
	 	By:	/s/ Nicholas Rutherfurd
	 	 	Name:	Nicholas Rutherfurd
	 	 	Title:	
        Principal

        

	 	 	 	 
	 	NS CO-INVESTMENT LLC
	 	 	 	 
	 	By:	/s/ Owen Littman
	 	 	Name:	Owen Littman
	 	 	Title:	Authorized Signatory

 

	 	cowen and company, llc, as Noteholder

By: COWEN HOLDINGS, INC., its sole member

	 	 	 	 
	 	By:	/s/ Owen Littman
	 	 	Name:	Owen Littman
	 	 	Title:	Authorized Signatory

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]